English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52769649    ???header.onlineuser??? :  654
???header.sponsordeclaration???
 		 
???search.scope??? ???search.advance???
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???
???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
Repositories
Author
Title
Date
???ui.leftmenu.statisticschart???
???ui.leftmenu.realtimefacts???
???ui.leftmenu.trend???

???index.news???
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

???ui.leftmenu.copyrighttitle???
???ui.leftmenu.copyrightpublisher???
???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
???tair.name??? >  ???browser.page.title.author???

"besse b"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 14  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:09:04Z Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Shaw A.T.; Solomon B.J.; Chiari R.; Riely G.J.; Besse B.; Soo R.A.; Kao S.; Chia-Chi Lin; Bauer T.M.; Clancy J.S.; Thurm H.; Martini J.-F.; Peltz G.; Abbattista A.; Li S.; Ou S.-H.I.
臺大學術典藏 2022-09-15T01:08:57Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S.; Shaw A.T.; Besse B.; Felip E.; Solomon B.J.; Soo R.A.; Bearz A.; Gadgeel S.M.; Chia-Chi Lin; Kao S.; Seto T.; Masters E.T.; Abbattista A.; Clancy J.S.; Thurm H.; Reisman A.; Peltz G.; Ross Camidge D.
臺大學術典藏 2020-05-26T09:27:15Z Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer Hensing T; Lee C; Gupta N; Pradhan R; Qian J; Qin Q; Scappaticci F.A; Ricker J.L; Carlson D.M; Soo R.A.; Tan E.-H;Goss G.D;Salgia R;Besse B;Gandara D.R;Hanna N.H;Chih-Hsin Yang;Thertulien R;Wertheim M;Mazieres J;Hensing T;Lee C;Gupta N;Pradhan R;Qian J;Qin Q;Scappaticci F.A;Ricker J.L;Carlson D.M;Soo R.A.; Tan E.-H; Goss G.D; Salgia R; Besse B; Gandara D.R; Hanna N.H; CHIH-HSIN YANG; Thertulien R; Wertheim M; Mazieres J
臺大學術典藏 2020-05-26T09:27:15Z Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer Hensing T; Lee C; Gupta N; Pradhan R; Qian J; Qin Q; Scappaticci F.A; Ricker J.L; Carlson D.M; Soo R.A.; Tan E.-H;Goss G.D;Salgia R;Besse B;Gandara D.R;Hanna N.H;Chih-Hsin Yang;Thertulien R;Wertheim M;Mazieres J;Hensing T;Lee C;Gupta N;Pradhan R;Qian J;Qin Q;Scappaticci F.A;Ricker J.L;Carlson D.M;Soo R.A.; Tan E.-H; Goss G.D; Salgia R; Besse B; Gandara D.R; Hanna N.H; CHIH-HSIN YANG; Thertulien R; Wertheim M; Mazieres J
臺大學術典藏 2020-05-26T09:26:38Z Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry Mok T.S.K; CHIH-HSIN YANG; Ou S.-H.I; Pall G; Froesch P; Zalcman G; Gandara D.R; Riess J.W; Velcheti V; Zeidler K; Diebold J; Früh M; Michels S; Monnet I; Popat S; Rosell R; Karachaliou N; Rothschild S.I; Shih J.-Y; Warth A; Muley T; Cabillic F; Mazières J; Drilon A.; Gautschi O;Milia J;Filleron T;Wolf J;Carbone D.P;Owen D;Camidge R;Narayanan V;Doebele R.C;Besse B;Remon-Masip J;Janne P.A;Awad M.M;Peled N;Byoung C.-C;Karp D.D;Van Den Heuvel M;Wakelee H.A;Neal J.W;Mok T.S.K;Chih-Hsin Yang;Ou S.-H.I;Pall G;Froesch P;Zalcman G;Gandara D.R;Riess J.W;Velcheti V;Zeidler K;Diebold J;Fr?h M;Michels S;Monnet I;Popat S;Rosell R;Karachaliou N;Rothschild S.I;Shih J.-Y;Warth A;Muley T;Cabillic F;Mazi?res J;Drilon A.; Gautschi O; Milia J; Filleron T; Wolf J; Carbone D.P; Owen D; Camidge R; Narayanan V; Doebele R.C; Besse B; Remon-Masip J; Janne P.A; Awad M.M; Peled N; Byoung C.-C; Karp D.D; Van Den Heuvel M; Wakelee H.A; Neal J.W
臺大學術典藏 2020-05-26T09:26:38Z Targeting RET in patients with RET-rearranged lung cancers: Results from the global, multicenter RET registry Mok T.S.K; CHIH-HSIN YANG; Ou S.-H.I; Pall G; Froesch P; Zalcman G; Gandara D.R; Riess J.W; Velcheti V; Zeidler K; Diebold J; Früh M; Michels S; Monnet I; Popat S; Rosell R; Karachaliou N; Rothschild S.I; Shih J.-Y; Warth A; Muley T; Cabillic F; Mazières J; Drilon A.; Gautschi O;Milia J;Filleron T;Wolf J;Carbone D.P;Owen D;Camidge R;Narayanan V;Doebele R.C;Besse B;Remon-Masip J;Janne P.A;Awad M.M;Peled N;Byoung C.-C;Karp D.D;Van Den Heuvel M;Wakelee H.A;Neal J.W;Mok T.S.K;Chih-Hsin Yang;Ou S.-H.I;Pall G;Froesch P;Zalcman G;Gandara D.R;Riess J.W;Velcheti V;Zeidler K;Diebold J;Fr?h M;Michels S;Monnet I;Popat S;Rosell R;Karachaliou N;Rothschild S.I;Shih J.-Y;Warth A;Muley T;Cabillic F;Mazi?res J;Drilon A.; Gautschi O; Milia J; Filleron T; Wolf J; Carbone D.P; Owen D; Camidge R; Narayanan V; Doebele R.C; Besse B; Remon-Masip J; Janne P.A; Awad M.M; Peled N; Byoung C.-C; Karp D.D; Van Den Heuvel M; Wakelee H.A; Neal J.W
臺大學術典藏 2020-05-25T07:35:09Z Impact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC) Peters S; Shaw A.T; Besse B; Felip E; Solomon B.J; Soo R.A; Bearz A; Gadgee S.M; Chia-Chi Lin; Kao S; Seto T; Masters E.T; Abbattista A; Clancy J.S; Thurm H; Reisman A; Camidge D.R.
臺大學術典藏 2020-05-25T07:35:07Z ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non�Vsmall-cell lung cancer Shaw A.T; Solomon B.J; Besse B; Bauer T.M; Chia-Chi Lin; Soo R.A; Riely G.J; Ignatius Ou S.-H; Clancy J.S; Li S; Abbattista A; Thurm H; Satouchi M; Camidge D.R; Kao S; Chiari R; Gadgeel S.M; Felip E; Martini J.-F.
臺大學術典藏 2020-05-25T07:35:07Z Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study Solomon B.J; Shaw A.T.; Ignatius Ou S.-H; Thurm H; Peltz G; Besse B; Bauer T.M; Felip E; Soo R.A; Camidge D.R; Chiari R; Bearz A; Chia-Chi Lin; Gadgeel S.M; Riely G.J; Tan E.H; Seto T; James L.P; Clancy J.S; Abbattista A; Martini J.-F; Chen J
臺大學術典藏 2020-05-25T07:34:59Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S; Shaw A.T; Besse B; Felip E; Solomon B.J; Soo R.A; Bearz A; Gadgeel S.M; Chia-Chi Lin; Kao S; Seto T; Masters E.T; Abbattista A; Clancy J.S; Thurm H; Reisman A; Peltz G; Ross Camidge D.

Showing items 1-10 of 14  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team